Paul Bisaro
Director · 4 filings · Latest: Jun 4, 2026
Keenova Therapeutics plc
MYRIAD GENETICS INC
Zoetis Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
MYGN | Paul Bisaro | Director | Jun 4, 2026 | Grant/Award | $0.00 | 59,701 | — | 157,142 | |
NONE | Paul Bisaro | Director | Jun 2, 2026 | Tax Withholding | — | 619 | — | 6,244 | |
NONE | Paul Bisaro | Director | Jun 2, 2026 | Option Exercise | — | 2,685 | — | 6,863 | |
MYGN | Paul Bisaro | Director | May 14, 2026 | Purchase | $3.69 | 7,500 | $27.6K | 97,441 | |
ZTS | Paul Bisaro | Director | May 13, 2026 | Purchase | $75.88 | 2,000 | $151.8K | 27,862 |